Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term efficacy of adalimumab in hyperimmunoglobulin D and periodic fever syndrome.

The Israel Medical Association journal : IMAJ - 1 Oct 2014

Di Gangi Marcella, Amato Giorgio, Converso Giovanni, Benenati Alessia, Leonetti Concetta, Borella Elisabetta, Doria Andrea, Foti Rosario

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adalimumab
Share to Antirheumatic Agents
Share to Injections, Subcutaneous
Share to Mevalonate Kinase Deficiency

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phosphotransferases (Alcohol Group Acceptor)

Share to Remission Induction

Source

Identifiers

PMID: 25438442

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term efficacy of adalimumab in hyperimmunoglobulin D and periodic fever syndrome.PMID 25438442Read ↗

Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infectionSemantic proximity Read ↗

Adalimumab Induces a Wound Healing Profile in Patients with Hidradenitis Suppurativa by Regulating Macrophage Differentiation and Matrix Metalloproteinase ExpressionSemantic proximity Read ↗

Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: experience from a consecutive cohort of inflammatory bowel disease patients.Semantic proximity Read ↗

Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.Semantic proximity Read ↗

Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphisms.Semantic proximity Read ↗

Anifrolumab to treat a monogenic interferonopathy.Semantic proximity Read ↗

Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic BiomarkersSemantic proximity Read ↗

Identification of HLA-DRB1 association to adalimumab immunogenicity.Semantic proximity Read ↗

Tocilizumab and adalimumab in an 18q deletion syndrome patient with chronic arthritis.Semantic proximity Read ↗

A Cell-Based Reporter Gene Assay for TNF-α Neutralization: Analytical Qualification and Application to Adalimumab and Its BiosimilarsSemantic proximity Read ↗

Clinical experience with adalimumab in a multicenter Swiss cohort of patients with Crohn's disease.Semantic proximity Read ↗

Successful use of secukinumab in Netherton syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.